<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03455920</url>
  </required_header>
  <id_info>
    <org_study_id>Sleep Apnea Supernurse</org_study_id>
    <nct_id>NCT03455920</nct_id>
  </id_info>
  <brief_title>Management of Sleep Apnea Patients by a Clinical Nurse (Supernurse)</brief_title>
  <official_title>Management of Sleep Apnea Patients by a Clinical Nurse (Supernurse)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Annie C Lajoie</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Laval University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sleep apnea is a prevalent problem and references for the evaluation of this condition often
      exceeds the sleep clinic's capacity thus creating important delays in the patients' care.

      The overall goal of this project is to assess the feasibility and the non-inferiority of
      integrating a clinical nurse, or supernurse, to the initial consultation team.

      The hypothesis is that the integration of a clinical nurse to the sleep clinic's evaluation
      team is non inferior in terms of patients' outcomes such as improvement of symptoms and
      quality of life as well as adherence to treatment.

      This study is supported by funding dedicated to teaching and research activities related to
      sleep-disordered breathing.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 19, 2017</start_date>
  <completion_date type="Actual">April 30, 2020</completion_date>
  <primary_completion_date type="Actual">April 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement in symptoms</measure>
    <time_frame>Assessed at three months</time_frame>
    <description>Based on the Epworth Sleepiness scale (ranging from 0 to 24 points, higher values indicates increased sleepiness)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Quebec Quality of Life Questionnaire</measure>
    <time_frame>Assessed at three months</time_frame>
    <description>Based on the Quebec's quality of life questionnaire. It has 32 items scored on a 7 points Likert scale, providing a quality of life score for five different domains (with 4 to 7 items per domain):1- Hypersomnolence 2- Diurnal symptoms 3- Nocturnal symptoms 4- Emotions and 5- Social interactions.
The lower the score, the higher the impact on the affected domain. Minimal clinically important difference differs for each domain. Lacasse et al. defined this value as such : hypersomnolence, 1.8; diurnal symptoms, 2.0; nocturnal symptoms, 1.5; emotions, 1.1; social interactions, 2.5.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Improvement in symptoms</measure>
    <time_frame>Assessed at six months</time_frame>
    <description>Based on the Epworth Sleepiness scale (ranging from 0 to 24 points, higher values indicates increased sleepiness)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Quebec Quality of life questionnaire</measure>
    <time_frame>Assessed at six months</time_frame>
    <description>Based on the Quebec's quality of life questionnaire. It has 32 items scored on a 7 points Likert scale, providing a quality of life score for five different domains (with 4 to 7 items per domain):1- Hypersomnolence 2- Diurnal symptoms 3- Nocturnal symptoms 4- Emotions and 5- Social interactions.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Positive pressure treatment adherence</measure>
    <time_frame>Assessed at six months</time_frame>
    <description>Number of hours used per night according to CPAP report</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mandibular advancement device treatment adherence</measure>
    <time_frame>Assessed at six months</time_frame>
    <description>According to the patient's usage report</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weight loss treatment adherence</measure>
    <time_frame>Assessed at six months</time_frame>
    <description>Changes from baseline weight (kg)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Positional therapy</measure>
    <time_frame>Assessed at six months</time_frame>
    <description>Proportion of time spent supine at baseline and at control cardio-respiratory recording</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">200</enrollment>
  <condition>Sleep Apnea Syndromes</condition>
  <condition>Sleep Apnea</condition>
  <condition>Multidisciplinary Communication</condition>
  <condition>Sleep Apnea, Obstructive</condition>
  <arm_group>
    <arm_group_label>Multidisciplinary arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients randomized in this group will have their first sleep clinic evaluation with the clinical nurse. She will then discuss each case with the pulmonologist and validate the diagnostic and therapeutic avenue.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pulmonologist arm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients randomized in this group will have their first sleep clinic evaluation with the pulmonologist.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Clinical nurse (supernurse) evaluation</intervention_name>
    <description>The first evaluation of the patient refered to the sleep clinic will be performed by the clinical nurse then discussed with the pulmonologist in charge.</description>
    <arm_group_label>Multidisciplinary arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Pulmonologist evaluation</intervention_name>
    <description>The first evaluation of the patient refered to the sleep clinic will be performed only by the pulmonologist.</description>
    <arm_group_label>Pulmonologist arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients referred to the ''Institut Universitaire de Cardiologie et Pneumologie de
             Québec'' 's sleep clinic who have undergone a cardiorespiratory polygraphy.

          -  Body mass index (BMI) between 27-35 kg/m2;

          -  Apnea-Hypopnea Index (ADI) equal or above 20 events per hour with less than 5 events
             per hour of central origin;

          -  Oxygen Desaturaton Index (ODI) equal or above 10 events per hour;

          -  Percentage of time spent below 90% of oxygen saturation equal or less than 10%

        Exclusion criteria :

        - Patients not meeting the above inclusion criteria.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec (CRIUCPQ)</name>
      <address>
        <city>Quebec City</city>
        <state>Quebec</state>
        <zip>G1V4G5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <reference>
    <citation>Antic NA, Buchan C, Esterman A, Hensley M, Naughton MT, Rowland S, Williamson B, Windler S, Eckermann S, McEvoy RD. A randomized controlled trial of nurse-led care for symptomatic moderate-severe obstructive sleep apnea. Am J Respir Crit Care Med. 2009 Mar 15;179(6):501-8. doi: 10.1164/rccm.200810-1558OC. Epub 2009 Jan 8.</citation>
    <PMID>19136368</PMID>
  </reference>
  <reference>
    <citation>Chai-Coetzer CL, Antic NA, Rowland LS, Reed RL, Esterman A, Catcheside PG, Eckermann S, Vowles N, Williams H, Dunn S, McEvoy RD. Primary care vs specialist sleep center management of obstructive sleep apnea and daytime sleepiness and quality of life: a randomized trial. JAMA. 2013 Mar 13;309(10):997-1004. doi: 10.1001/jama.2013.1823.</citation>
    <PMID>23483174</PMID>
  </reference>
  <reference>
    <citation>Robertson S, Maxwell C, McGarry GW, MacKenzie K. A nurse-led snoring clinic: how we do it. Clin Otolaryngol. 2009 Apr;34(2):158-61. doi: 10.1111/j.1749-4486.2009.01898.x.</citation>
    <PMID>19413617</PMID>
  </reference>
  <reference>
    <citation>Tomlinson M, John Gibson G. Obstructive sleep apnoea syndrome: a nurse-led domiciliary service. J Adv Nurs. 2006 Aug;55(3):391-7.</citation>
    <PMID>16866834</PMID>
  </reference>
  <reference>
    <citation>Chai-Coetzer CL, Antic NA, Rowland LS, Catcheside PG, Esterman A, Reed RL, Williams H, Dunn S, McEvoy RD. A simplified model of screening questionnaire and home monitoring for obstructive sleep apnoea in primary care. Thorax. 2011 Mar;66(3):213-9. doi: 10.1136/thx.2010.152801. Epub 2011 Jan 20.</citation>
    <PMID>21252389</PMID>
  </reference>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>December 20, 2017</study_first_submitted>
  <study_first_submitted_qc>March 5, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 7, 2018</study_first_posted>
  <last_update_submitted>July 16, 2020</last_update_submitted>
  <last_update_submitted_qc>July 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec</investigator_affiliation>
    <investigator_full_name>Annie C Lajoie</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>January 12, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/20/NCT03455920/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

